Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.

Administration of human pancreatic tumor growth hormone (GH) releasing factor (hpGRF[1-40]) as a single injection to normal human subjects stimulates the secretion of GH in a dose-responsive manner. In the present studies, hpGRF(1-40) was infused in a graded stepwise manner over a 6-h period in orde...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Clin Invest
Päätekijät:	Webb, C B, Vance, M L, Thorner, M O, Perisutti, G, Thominet, J, Rivier, J, Vale, W, Frohman, L A
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Clinical Investigation 1984
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC425189/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6429198/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111424
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!